QUOTE(abcn1n @ Jan 15 2021, 03:52 PM)
What fund you buy for China then? Was supposed to look up a China fund the last week but forgot all about it (currently only have TA global tech). Sorry, can't read Chinese.
My fund is a mix of Chindia equities and Malaysia bonds, Eastspring Investments Asia Select Income Fund. I bought via FSM.
https://www.eastspring.com/my/funds-and-sol...s?fundcode=E017The Chindia equity is invested via a SG mutual fund called Dragon Peacock Fund, also by Eastspring (so it's a fund-of-fund). The MY bonds are managed by the Malaysia Eastspring managers themselves.
https://www.eastspring.com/sg/funds/fund-pr...20%E2%80%93%20AAs for the Chinese article, Google translate will help you to some extent. I am not a good translator, nor a lawyer (consult lawyer Hansel if in doubt).
Here's my translated article:
QUOTE
Looking at last year's IPO market, Chinese shares are in the investment spotlight, pioneered by JD.com (9618) and Netease (9999), the whole year saw 9 stocks return to HK for listing, attracting a combined 130 billion HKD capital. Regulators are giving the green light to Chinese shares. However, Ming Pao understood that HKIFA (HK Investment Funds Association), upon studying the industry's views and opinions, would like to suggest HKEX to provide more information on protection rules in place to safeguard investors under the secondary-listing system. One notable issue is that Chinese stocks already have lose regulations in their US listing, but many regulatory disclosure are still exempted in the HK listing.
Under the current system. Greater China issuers conduct secondary listing in HK under Chapter 19C of the Listing Rules and enjoy automatic exemptions of up to 78 clauses and appendices. According to the document, HKIFA reckons that Chinese shares receiving the exemptions pertaining to related-parties transactions and major transactions disclosure, acquisition rules, and corporate governance rules are exactly those that are easily involved in conflicts of interest, especially related-parties transactions, which is used frequently to infringe the rights of minority shareholders.
(https://www.hkex.com.hk/-/media/HKEX-Market/Listing/Rules-and-Guidance/Listing-Rules-Contingency/Main-Board-Listing-Rules/Equity-Securities/chapter_19c.pdf?la=en) - This Chapter 19C URL is my own addition
HKIFA states that the main reason HKEX takes a soft stand is because current Chinese shares' regulations rely on their IPO exchange and corresponding regulators; well-recognized exchanges like NYSE and NASDAQ are mature markets. However, HKIFA suggests that those Chinese shares listed in the primary exchange are already considered Foreign Private Issuer (FPI), whose regulations are already lax compared to domestic US companies, and the exemption given by HKEX gives rise to "double exemption" treatment for these companies.
Looking into SFC information, FPIs are not required to abide by "Regulation FD" (Fair Disclosure), and that regulation is supposed to prohibit companies to reveal part of important information to investors and analysts before announcing it to the public. Also, companies are not required to issue quarterly reports, unless it is released outside of US market. Other "benefits" include, managers who hold 10% or more of their company's shares are not required to disclose to SFC their company's shares transaction. Norton Rose Fullbright (a law firm) reported that FPI's disclosure requirement can be fulfilled easily.
HKIFA's CEO Sally Wong replied to Ming Pao and asserts that Chinese shares' regulation are lax in mainland China, and they are exempted from more regulations in HK, more so given a majority of their shares are of different voting rights (following the WVR structure), resulting in high governance risk for such companies, yet HKEX never points out the issue. She welcomed investment opportunities in Chinese shares, but suggested that HKEX should significantly reduce the amount of exemptions given under the Listing Rules, and solid rationales should be given for those that are exempted. The public should also be educated about the real risk of investing in Chinese shares.
When asked whether they would be worried about governance risk of Chinese shares, large international fund Franklin Templeton's spokesperson replied to Ming Pao that HKEX and SC (HK Securities Commission) documents have listed all Listing Rules-related exemptions, investors can do their due diligence if they need to. Franklin Templeton's Emerging Markets Head of Trading, George Molina says that funds under Franklin Templeton will consider ESG factors when researching companies. He also further elaborates that HKEX's secondary listing is one of the most effective means to allow Asian investors to invest Alibaba-like overseas listed Chinese stocks.
Took an hour to finish haha. Forgive me for errors. (I am not a law or finance guy).
This post has been edited by TOS: Jan 15 2021, 05:33 PM